Dense breast tissue is not a disease or an abnormality. It’s a normal variation in breast composition that roughly half of women have. But it does matter for two reasons: it moderately increases the risk of developing breast cancer, and it makes cancer harder to spot on a standard mammogram. Neither of those facts means dense breasts are “bad,” but they do mean you should understand what density means for your screening plan.
What Breast Density Actually Means
Breasts are made up of two main types of tissue: fatty tissue and fibroglandular tissue (a mix of connective tissue and milk-producing glands). Breast density describes the ratio between the two. When a radiologist reads your mammogram, they classify your density into one of four categories:
- A: Almost entirely fatty
- B: Scattered areas of fibroglandular density
- C: Heterogeneously dense
- D: Extremely dense
Categories C and D are considered “dense.” You can’t feel density through a self-exam or predict it from breast size. A large-breasted person can have mostly fatty tissue, and a small-breasted person can have extremely dense tissue. It only shows up on imaging.
How Common Dense Breasts Are
Dense breast tissue is especially common in younger women. About 74% of women between 40 and 49 have dense breasts on their screening mammograms. That number drops to 57% in the 50s, 44% in the 60s, and 36% in the 70s. The trend is clear: density tends to decrease with age as fibroglandular tissue is gradually replaced by fat.
Several other factors influence density. Lower body weight is associated with denser tissue, since gaining weight adds fatty tissue to the breasts (though it doesn’t reduce the dense tissue already there). Higher estrogen levels, whether from pregnancy, breastfeeding, or hormone replacement therapy, can also increase density. Genetics play a significant role too.
The Cancer Risk in Context
Women with extremely dense breasts (category D) have roughly twice the risk of breast cancer compared to women with average density. That sounds alarming, but context matters. The baseline risk of developing breast cancer in any given year is relatively low for most women, so doubling a small number still produces a small number. Dense tissue is one risk factor among many, alongside family history, age, and genetics.
The biological explanation involves the tissue itself. Dense areas contain more glandular and stromal cells, which are the types of cells where cancers originate. These areas also produce higher levels of estrogen locally, which can fuel cell growth. Breast density is considered an independent risk factor, meaning it adds to your overall risk profile on top of whatever other risk factors you may carry.
Why Dense Tissue Makes Screening Harder
This is the more immediate, practical concern. On a mammogram, both dense tissue and tumors appear white. Fatty tissue appears dark. So finding a white tumor against a white background is significantly harder than finding it against a dark one. Radiologists call this the “masking” effect.
The numbers are stark. Digital mammography detects about 93% of cancers in women with mostly fatty breasts but only about 73% in women with extremely dense breasts. That 20-percentage-point gap means more cancers get missed in dense breasts and are instead found between scheduled screenings, sometimes at a later stage. This masking problem, not just the biological risk, is a major reason density matters.
What Your Mammogram Report Will Tell You
As of September 2024, all mammography facilities in the United States are required by an FDA rule to notify you about your breast density. If your tissue is dense, the notification will state that dense tissue makes it harder to find cancer on a mammogram and raises the risk of developing breast cancer. It will also note that additional imaging tests may help. If your tissue is not dense, you’ll receive a simpler version of the same message.
This means you no longer need to ask about your density or hope your state has a notification law. Every mammogram report now includes it. Look for the patient summary that comes with your results.
Supplemental Screening Options
If you have dense breasts and a normal mammogram, the question becomes whether additional screening is worthwhile. The U.S. Preventive Services Task Force currently says there isn’t enough evidence to broadly recommend supplemental screening for all women with dense breasts, but it also notes that clinicians should use their judgment based on your individual situation. Several supplemental tools exist, and their detection rates vary considerably.
Breast Ultrasound
Ultrasound is the most widely available add-on. In large studies, handheld ultrasound performed by a physician found an additional 4 to 5 cancers per 1,000 women screened that mammography alone missed. Automated ultrasound systems, where a technologist positions the device and a computer captures the images, find roughly 2 per 1,000 additional cancers. Ultrasound is noninvasive and doesn’t use radiation, but it does come with higher recall rates, meaning more women get called back for findings that turn out to be benign.
Breast MRI
MRI is the most sensitive tool available. In one study of women who had already had both a normal mammogram and a normal ultrasound, MRI still found an additional 10.6 cancers per 1,000 women screened. Another trial found 14.7 additional cancers per 1,000 even after three rounds of annual ultrasound screening. The tradeoff is cost, time, and accessibility. A standard breast MRI takes about 45 minutes, costs around $950 without insurance, and typically requires prior authorization.
Abbreviated (Fast) Breast MRI
A newer option called abbreviated or “fast” breast MRI takes 7 to 20 minutes and costs $250 to $500 out of pocket. It captures fewer images than a full MRI but still detects more cancers than mammography alone in women with dense breasts. The downsides: it’s not available at all imaging centers, most insurance plans don’t cover it, and you’ll still need a doctor’s referral. It supplements mammography rather than replacing it, since some cancers are actually easier to see on a mammogram.
What You Can and Can’t Change
You can’t exercise your way to less dense breasts or take a supplement to change your tissue composition. Density is largely determined by genetics, age, and hormonal factors. It naturally decreases after menopause for most women. Gaining weight adds fatty tissue to the breasts but doesn’t reduce the dense tissue already present, so it wouldn’t meaningfully improve screening accuracy.
If you’re taking hormone replacement therapy and have dense breasts, that’s worth discussing with your provider, since HRT can increase density. But for most women, the practical focus should be on screening strategy rather than trying to change the tissue itself. Knowing your density category, understanding what it means for mammogram accuracy, and having a conversation about whether supplemental imaging makes sense for your overall risk profile are the steps that actually make a difference.